
The technology is based on the injection of muscle cells and could replace strength training in the future.
AI-generated summary
Researchers from the Institute of Zoology of the Chinese Academy of Sciences have developed myograft technology to replace strength training.
Brief retelling from RIA II
Researchers from the Institute of Zoology of the Chinese Academy of Sciences have developed a technology that can replace strength training with injections.
The method is based on the introduction of myografts - muscle cells that independently organize themselves into functional tissue.
The technology is primarily addressed to bedridden patients, people with paralysis, after severe injuries, as well as elderly patients with osteoporosis and Alzheimer's disease.
MOSCOW, September 5 - RIA Novosti. An injection capable of pumping up muscles, developed at the Institute of Zoology of the Chinese Academy of Sciences, may become available to Russians if it undergoes clinical trials on humans, says Anna Divinskaya, a biochemist and specialist in the correction of eating behavior.
As the expert said, researchers from the Institute of Zoology of the Chinese Academy of Sciences have developed a technology that can replace strength training with a regular injection. The method, she says, is based on so-called myografts - muscle cells extracted from the quadriceps muscle, and after subcutaneous injection they independently organize into functional tissue.
“In the future, if the technology passes clinical trials on humans, it may also be of interest to healthy people who want to maintain muscle mass without going to the gym - for example, due to lack of time or health restrictions. It is possible that Russians will also be able to use it,” Divinskaya noted in an interview with NEWS.ru.
According to her, in experiments on mice, after administration of the drug, they increased muscle mass, strength and bone density, and also decreased signs of systemic inflammation. In addition, as the expert noted, the rodents’ liver function improved and the body’s energy consumption increased.
AI outlook — possibilities, not facts
Clinical trials of technology on humans
Possible · Within months

The summer of 2026 in Russia became the warmest in the history of meteorological observations since 1891, said Mikhail Leus, leading specialist at the Phobos weather center. Records were recorded in the Urals and Siberia, as well as in a number of other countries.

Researchers from the Institute of Zoology of the Chinese Academy of Sciences have created a technology for replacing strength training with an injection with myografts. The method can help bedridden patients and elderly people, and in the future it can become available to Russians after testing.

The Ig Nobel Prize was awarded for the 36th time in Zurich for research that first makes you laugh and then makes you think. The laureates studied the biomechanics of kissing, the aerodynamics of blowing your nose, the behavior of rich people, snakes, cockroach milk and other unusual topics. This was the first time the ceremony was held outside the United States due to stricter visa policies.

Scientists found that semaglutide, an anti-diabetes and obesity drug, extended the life of elderly female mice by nearly 100 days and improved their muscle and cognitive function, while reducing signs of aging such as chronic inflammation and decreased tissue regeneration. The drug also replicated the effects of a low-calorie diet, but with added benefits in some areas. However, the results were only obtained in mice and cannot be directly translated to humans.

In the Tavrida cave in Crimea, over eight years of excavations, three tons of bones of prehistoric animals of the early Pleistocene were discovered, including the skull of a giant hyena and the bones of saber-toothed cats. The research is carried out by specialists from the Paleontological Institute of the Russian Academy of Sciences, and a temporary exhibition is open in the Paleontological Museum of Moscow.

Leading researcher at the Institute of Solar-Terrestrial Physics SB RAS Sergei Yazev warned that if the gravitational correction of the trajectory fails in September 2024, the European interplanetary probe JUICE may collide with the Earth. A successful maneuver requires filigree precision. The device, launched in April 2023 on an Ariane 5 rocket, should undergo a series of maneuvers near Earth and Venus by 2029, reach Jupiter by mid-2031 and conduct 35 flybys of its moons, before entering Ganymede orbit by the end of 2034. The main goal of the mission is to search for conditions suitable for life on the moons of Jupiter.